STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Electromed, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Electromed, Inc. (ELMD) reported the results of its annual shareholder meeting held on November 14, 2025. Shareholders elected all nominated directors to the Board, with each nominee receiving substantially more votes "for" than "withheld." Other management proposals also received strong support, including the advisory vote approving executive compensation. Shareholders additionally voted on how often they want an advisory vote on executive pay, and the Board determined, based on these results, to continue including this vote in the proxy materials on an annual basis. These outcomes keep the company’s governance structure and executive pay practices largely unchanged.

Positive
  • None.
Negative
  • None.
false 0001488917 0001488917 2025-11-14 2025-11-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
     
 
FORM 8-K 
     
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): November 14, 2025
     
 
ELECTROMED, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Minnesota
001-34839
41-1732920
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(I.R.S. Employer Identification
Number)
 
500 Sixth Avenue NW
New Prague, MN 56071
(Address of Principal Executive Offices) (Zip Code)
 
(952) 758-9299
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.01 par value
 
ELMD
 
NYSE American LLC
(Title of each class)
 
(Trading Symbol)
 
(Name of each exchange on which registered)
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 5.07
Submission of Matters to a Vote of Security Holders.
 
At the annual meeting of shareholders of Electromed, Inc. (the “Company”) held on November 14, 2025, the following proposals, each as described in further detail in the definitive proxy statement filed on September 30, 2025, were voted upon by our shareholders as set forth below:
 
1.
The following individuals designated by our Board as nominees for director were elected for a one-year term or until a successor has been elected and qualified, thereby setting the number of directors at eight, with voting as follows:
 
Name
For
Withheld
Broker Non-Votes
James L. Cunniff
5,022,691
20,061
1,416,368
Stan K. Erickson
4,958,039
84,713 1,416,368
Gregory J. Fluet
4,686,278
356,474
1,416,368
Joseph L. Galatowitsch
4,969,344
73,408
1,416,368
Kathleen S. Skarvan
5,007,992
34,760
1,416,368
Andrew J. Summers
4,967,176
75,576
1,416,368
Kathleen A. Tune
4,964,920
77,832
1,416,368
Andrea M. Walsh
4,965,887
76,865
1,416,368
 
 
2.
Our shareholders ratified the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026, with voting as follows:
 
   
For
Against
Abstain
 
   
6,435,180
5,610
18,330
 
 
3.
Our shareholders approved, on a non-binding and advisory basis, our executive compensation, with voting as follows:
 
 
For
Against
Abstain
Broker Non-Votes
 
4,713,558
309,673
19,521
1,416,368
 
 
4.
Our shareholders recommended, on a non-binding and advisory basis, that votes on named executive officer compensation should occur every year, with voting as follows:
 
 
1 Year
2 Years
3 Years
Abstain
Broker Non-Votes
 
4,783,259
6,533
237,314
15,646
1,416,368
 
 
Based on the voting results, our Board of Directors has determined to continue to include a shareholder vote to approve executive compensation in its proxy materials on an annual basis.
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ELECTROMED, INC.
     
Date: November 18, 2025
By:
/s/ Bradley M. Nagel
 
Name:
Bradley M. Nagel
 
Title:
Chief Financial Officer
 
 
 

FAQ

What did Electromed, Inc. (ELMD) announce in this Form 8-K?

Electromed, Inc. reported the results of its annual shareholder meeting held on November 14, 2025, including director elections and advisory votes on executive compensation.

Were Electromed, Inc. (ELMD) director nominees elected at the 2025 annual meeting?

Yes. All named director nominees received more votes "for" than "withheld," and were elected to the Board of Directors.

How did Electromed, Inc. (ELMD) shareholders vote on executive compensation?

Shareholders approved the advisory proposal on executive compensation with a strong majority of votes cast in favor.

How often will Electromed, Inc. (ELMD) hold say-on-pay votes going forward?

Based on the shareholder vote, the Board determined it will continue to include a shareholder advisory vote to approve executive compensation in its proxy materials on an annual basis.

Did the Electromed, Inc. (ELMD) meeting results change the company’s governance structure?

No major changes were indicated. Directors were re-elected and shareholders supported existing executive compensation practices and the annual say-on-pay framework.

What is the significance of broker non-votes in Electromed, Inc.’s 2025 meeting results?

The voting results tables show broker non-votes on certain proposals, indicating some shares were not entitled or instructed to vote on those specific items, but the proposals still passed.

Electromed

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

205.43M
6.58M
21.3%
53.31%
3.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE